Also trades as: 0R2M.L (LSE) · $vol 1M
REGN NASDAQ
Regeneron Pharmaceuticals, Inc.
1W: -9.8%
1M: -14.0%
3M: -17.6%
YTD: -17.1%
1Y: +4.8%
3Y: -13.0%
5Y: +25.0%
$638.88
-3.71 (-0.58%)
Weekly Expected Move ±4.6%
$634
$666
$698
$730
$763
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$15B
Revenue
+5.9% YoY
$4B
Net Income
-1.7% YoY
$4B
Free Cash Flow
+37.6% YoY
81.4%
Gross Margin
17.8%
Op. Margin
20.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE14.6%
ROA11.3%
ROIC12.3%
Valuation
P/E15.0
P/B2.1
EV/EBITDA13.5
Leverage
Debt/Equity0.09
Current Ratio4.13
Interest Cov.108.4x
Quality Scores
Piotroski F6/9
Altman Z7.80
Beneish M-2.47